Latest Period
Q2 2026
Security Snapshot
SAB Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (SABS) Institutional Ownership
CUSIP: 78397T202
13F Institutional Holders and Ownership History from Q4 2023 to Q2 2026
Institutions Reporting
86
Shares (Excl. Options)
68,397,312
Price
$3.90
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- SABS on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 68,397,312
- Total 13F value
- $266,750,251
- Portfolio coverage rank
- 0%
- Share change
- -802,325
- Value change
- -$2,811,505
- Number of holders
- 86
- Shares outstanding
- 226,597,678
- SEC-reported price per share
- $3.56
- Insider filing price
- $3.56
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- SABS - SAB Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 78397T202.
- 86 institutions reported positions in Q2 2026.
- 11 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 75 to 86 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $265,013,025 to $266,750,251.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 86 institutions filings for Q2 2026.
Security key
78397T202
Latest holder period
Q2 2026
13F holders
86
13D/G owners
11
CIK / CUSIP context first
Open Q2 2026 holders
SABS full holder history
SAB Biotherapeutics, Inc. SEC filings
SAB Biotherapeutics, Inc. company facts
SAB Biotherapeutics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 78397T202:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
11
Security
SABS
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. | 10% | 0% | $89,642,948 | -$13,043,812 | 22,637,108 | -13% | Vivo Opportunity Fund Holdings, L.P. | 30 Jun 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 9.9% | 0% | $38,055,014 | +$9,102,563 | 9,609,852 | +31% | RA Capital Management, L.P. | 06 Aug 2026 |
| Commodore Capital LP | 9.9% | 0% | $35,434,753 | +$17,523,764 | 8,948,170 | +98% | Commodore Capital LP | 30 Jun 2026 |
| Caligan Partners LP | 8.8% | -16% | $31,550,140 | 7,967,207 | 0% | Caligan Partners LP | 30 Jun 2026 | |
| BALYASNY ASSET MANAGEMENT L.P. | 9.4% | -5.4% | $28,612,738 | +$8,456,580 | 7,225,439 | +42% | BALYASNY ASSET MANAGEMENT L.P. | 30 Jun 2026 |
| PERCEPTIVE ADVISORS LLC | 7.3% | -14% | $26,244,904 | +$775,202 | 6,627,501 | +3% | Perceptive Advisors LLC | 30 Jun 2026 |
| Adage Capital Management, L.P. | 8.4% | $25,365,990 | 6,405,553 | Adage Capital Management, L.P. | 30 Jun 2026 | |||
| Woodline Partners LP | 6.8% | -31% | $21,603,206 | -$6,615,283 | 5,455,355 | -23% | Woodline Partners LP | 30 Jun 2026 |
| BIOTECHNOLOGY VALUE FUND L P | 9.1% | -8.9% | $18,761,910 | -$1,598,505 | 4,761,906 | -7.9% | BVF PARTNERS L P/IL | 31 Dec 2025 |
| MILLENNIUM MANAGEMENT LLC | 5.1% | $13,385,397 | 3,432,153 | Millennium Management LLC | 24 Apr 2026 | |||
| RTW INVESTMENTS, LP | 3.2% | -68% | $6,253,970 | +$2,218,090 | 1,587,302 | +55% | RTW Investments, LP | 31 Dec 2025 |
As of 30 Jun 2026, 86 institutional investors reported holding 68,397,312 shares of SAB Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (SABS). This represents 30% of the company’s total 226,597,678 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
28%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Caligan Partners LP | 3.5% | 7,967,207 | 0% | 1.5% | $31,072,107 |
| Vivo Capital, LLC | 3.2% | 7,299,909 | -36% | 2.6% | $28,469,645 |
| PERCEPTIVE ADVISORS LLC | 2.9% | 6,627,501 | +3% | 0.4% | $25,847,254 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.8% | 6,405,553 | +88% | 0.04% | $24,981,657 |
| RA CAPITAL MANAGEMENT, L.P. | 1.9% | 4,401,500 | 0% | 0.15% | $17,165,850 |
| Balyasny Asset Management L.P. | 1.7% | 3,760,439 | 0% | 0.03% | $14,665,712 |
| BlackRock, Inc. | 1.4% | 3,066,016 | +918% | 0% | $11,957,462 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.3% | 2,972,929 | +19% | 0% | $11,594,423 |
| Commodore Capital LP | 1.3% | 2,870,000 | -35% | 0.67% | $11,193,000 |
| MILLENNIUM MANAGEMENT LLC | 1.2% | 2,749,087 | -9.4% | 0.01% | $10,721,439 |
| Spruce Street Capital LP | 0.97% | 2,198,502 | 0% | 1.7% | $8,574,158 |
| Sessa Capital IM, L.P. | 0.97% | 2,198,457 | 0% | 0.15% | $8,573,982 |
| Affinity Asset Advisors, LLC | 0.67% | 1,525,000 | +165% | 0.29% | $5,947,500 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.65% | 1,481,660 | 0% | 0.11% | $5,778,474 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.56% | 1,277,185 | +323% | 0% | $4,981,704 |
| Woodline Partners LP | 0.52% | 1,180,355 | -59% | 0.01% | $4,603,385 |
| Ensign Peak Advisors, Inc | 0.52% | 1,172,641 | -15% | 0.01% | $4,573,300 |
| Propel Bio Management, LLC | 0.48% | 1,076,578 | +6.3% | 2.2% | $4,198,654 |
| Soleus Capital Management, L.P. | 0.4% | 900,000 | -14% | 0.12% | $3,510,000 |
| Seven Fleet Capital Management LP | 0.32% | 736,077 | +636% | 0.47% | $2,870,700 |
| AMERIPRISE FINANCIAL INC | 0.27% | 611,019 | -59% | 0% | $2,382,975 |
| STATE STREET CORP | 0.23% | 530,831 | +615% | 0% | $2,070,241 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.19% | 438,515 | 0% | $1,710,209 | |
| DV EQUITIES, LLC | 0.18% | 400,000 | 0.23% | $1,560,000 | |
| AWM Investment Company, Inc. | 0.17% | 375,000 | -6.2% | 0.13% | $1,462,500 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
11
Latest
Q2 2026
Rows shown
1-11 of 11
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 68,397,312 | $266,750,251 | -$2,811,505 | $3.90 | 86 |
| 2026 Q1 | 69,191,893 | $265,013,025 | +$122,542,646 | $3.83 | 75 |
| 2025 Q4 | 36,342,111 | $135,919,535 | +$25,718,819 | $3.74 | 48 |
| 2025 Q3 | 28,023,938 | $56,328,113 | +$52,469,483 | $2.01 | 34 |
| 2025 Q2 | 1,923,874 | $3,369,565 | -$378,633 | $1.76 | 25 |
| 2025 Q1 | 2,209,552 | $2,994,479 | -$1,776,863 | $1.36 | 26 |
| 2024 Q4 | 2,652,300 | $10,189,778 | -$1,266,185 | $3.79 | 26 |
| 2024 Q3 | 3,141,736 | $8,482,377 | +$68,507 | $2.70 | 24 |
| 2024 Q2 | 3,127,151 | $9,694,108 | -$923,501 | $3.10 | 21 |
| 2024 Q1 | 3,339,666 | $15,162,138 | -$15,603,353 | $4.54 | 23 |
| 2023 Q4 | 8,791,109 | $6,055,351 | +$6,055,351 | $0.69 | 3 |